Understanding Odyssey Alternative Trial
Exploring Odyssey Alternative Trial reveals several interesting facts. Patrick M. Moriarty, MD, reviews the findings of the
Key Takeaways about Odyssey Alternative Trial
- Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the
- Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the
- Prof Vera Bittner (University of Alabama at Brimingham, Birmingham, AL,US) discusses the
- Patrick O'Gara, MD, panelist for the
- AHA14:
Detailed Analysis of Odyssey Alternative Trial
Alirocumab vs Ezetimibe in patients with statin intolerance. For more resources from the European Heart Journal please click ... CSWN talks with Patrick M. Moriarty, MD, of the University of Kansas Medical Center, about the results of the ODESSY ... Patrick Moriarty, MD, one of the US National Coordinators for
During #ACC18, results from the
Stay tuned for more updates related to Odyssey Alternative Trial.
